Title
Safety of Remifentanil Infusion
The Effects of Maintenance a Remifentanil Infusion on the Hemodynamic Variables and Recovery Quality
Phase
Phase 4Lead Sponsor
Ankara Yildirim Beyazıt UniversityStudy Type
InterventionalStatus
Completed Results PostedIndication/Condition
Urinary Tract ProblemIntervention/Treatment
remifentanil ...Study Participants
42The effect of maintenance remifentanil infusion with target controlled infusion during laryngeal mask airway removal on hemodynamic parameters and emergence quality is going to be investigated.
In all patients (control group and remifentanil group induction of anesthesia will be achieved with desflurane and remifentanil.Anesthesia will be maintained with remifentanil (1-4 ng/mL) by TCI target controlled infusion, and desflurane . Throughout the surgery hemodynamic parameters are going to be recorded. As soon as the surgery has been finished, in control group remifentanil infusion and desflurane inhalation is going to be stopped.In remifentanil group,desflurane inhalation is going to be stopped and remifentanil infusion will be maintained until the removal of LMA. During the emergence period the time of eye opening, hemodynamic parameters and emergence quality (score 1-2)are going to be recorded.
1-4 ng/mL i.v. infusion during the surgery, maintenance dosage till LMA removal is 1.5 ng/mL.
Remifentanil:1.5ng/ml remifentanil infusion maintained at the end of the surgery
Control:Remifentanil stopped at the end of the surgery
Inclusion Criteria: ASA I-II status aged 18-60 years old presenting for ureterorenoscopy Exclusion Criteria: history of hypertension asthma and chronic obstructive lung disease recent respiratory tract infections
| Event Type | Organ System | Event Term |
|---|
cLMA removal was accepted as successful (score 1) if none of the complications coughing, teeth clenching, gross purposeful movements, breath holding, laryngospasm, and desatura- tion to SpO2\90% was observed. If any of these compli- cations was observed it was regarded as unsuccessful (score 2)
